Effect of kynurenic acid on development and aging in wild type and vermilion mutants of Drosophila melanogaster

Por Navrotskaya, Valeriya, Oxenkrug, Gregory
Publicado no Pharmacol Drug Dev Ther (2016)

Advances in managing type 2 diabetes: challenging old paradigms and developing new ones

Por Sattar, Naveed
Publicado em 2014

Insights Into Drug Resistance in Staphylococcus aureus

Publicado no Infectious Diseases (2021)

MTBDRplus and MTBDRsl Assays: Absence of Wild-Type Probe Hybridization and Implications for Detection of Drug-Resistant Tuberculosis

Por Seifert, Marva, Georghiou, Sophia B., Catanzaro, Donald, Rodrigues, Camilla, Crudu, Valeriu, Victor, Thomas C., Garfein, Richard S., Catanzaro, Antonino, Rodwell, Timothy C.
Publicado no J Clin Microbiol (2016)

Design and Evaluation of a Novel Matrix Type Multiple Units as Biphasic Gastroretentive Drug Delivery Systems

Por Lingam, Meka, Ashok, Thadisetty, Venkateswarlu, Vobalaboina, Madhusudan Rao, Yamsani
Publicado em 2008

Risk assessment score for drug eluting stent restenosis

Por Z. A. Gabbasov, I. S. Melnikov, S. V. Byazrova, S. G. Kozlov
Publicado em 2018-09-01

Monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease

Por Kaur, Sharminder, Kapoor, Vinod, Mahajan, Rajiv, Lal, Mohan, Gupta, Seema
Publicado em 2011

Chimeric Antigen Receptor T-Cell Therapy for the Community Oncologist

Por Maus, Marcela V., Levine, Bruce L.
Publicado no Oncologist (2016)

A human liver microphysiology platform for investigating physiology, drug safety, and disease models

Por Vernetti, Lawrence A, Senutovitch, Nina, Boltz, Robert, DeBiasio, Richard, Ying Shun, Tong, Gough, Albert, Taylor, D Lansing
Publicado no Exp Biol Med (Maywood) (2015)

Development of Inducible Leucine-rich Repeat Kinase 2 (LRRK2) Cell Lines for Therapeutics Development in Parkinson’s Disease

Por Huang, Liang, Shimoji, Mika, Wang, Juan, Shah, Salim, Kamila, Sukanta, Biehl, Edward R., Lim, Seung, Chang, Allison, Maguire-Zeiss, Kathleen A., Su, Xiaomin, Federoff, Howard J.
Publicado em 2013

Sex-dimorphic adverse drug reactions to immune suppressive agents in inflammatory bowel disease

Por Zelinkova, Zuzana, Bultman, Evelien, Vogelaar, Lauran, Bouziane, Cheima, Kuipers, Ernst J, van der Woude, C Janneke
Publicado em 2012

The Utility of Hedgehog Signaling Pathway Inhibition for Cancer

Por Sahebjam, Solmaz, Siu, Lillian L., Razak, Albiruni A.
Publicado em 2012

Treatment of Genetic Diseases: Current Trends in the Development of Biomedical Cell Products

Por O. A. Rachinskaya, M. A. Vodyakova, E. V. Melnikova, V. A. Merkulov
Publicado em 2019-12-01

Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery

Por Singh, Vimal K., Kalsan, Manisha, Kumar, Neeraj, Saini, Abhishek, Chandra, Ramesh
Publicado no Front Cell Dev Biol (2015)

Development of a Novel In Vitro Human Tissue-Based Angiogenesis Assay to Evaluate the Effect of Antiangiogenic Drugs

Por Woltering, Eugene A., Lewis, James M., Maxwell, P. Johnstone, Frey, Daniel J., Wang, Yi-Zarn, Rothermel, John, Anthony, Catherine T., Balster, Douglas A., O’Leary, J. Patrick, Harrison, Lynn H.
Publicado em 2003

A model qualification method for mechanistic physiological QSP models to support model‐informed drug development

Por Friedrich, CM
Publicado no CPT Pharmacometrics Syst Pharmacol (2016)

Developing a Patient-Directed Policy Framework for Managing Orphan and Ultra-Orphan Drugs Throughout Their Lifecycle

Por Menon, Devidas, Stafinski, Tania, Dunn, Andrea, Wong-Rieger, Durhane
Publicado no Patient (2015)

Circulating T cells to infliximab are detectable mainly in treated patients developing anti‐drug antibodies and hypersensitivity reactions

Por Vultaggio, A., Petroni, G., Pratesi, S., Nencini, F., Cammelli, D., Milla, M., Prignano, F., Annese, V., Romagnani, S., Maggi, E., Matucci, A.
Publicado no Clin Exp Immunol (2016)

Semi-Synthetic Analogues of Cryptolepine as a Potential Source of Sustainable Drugs for the Treatment of Malaria, Human African Trypanosomiasis, and Cancer

Por Yabalu Z. Abacha, Yabalu Z. Abacha, Arnold Donkor Forkuo, Stephen Y. Gbedema, Nimisha Mittal, Sabine Ottilie, Frances Rocamora, Elizabeth A. Winzeler, Donelly A. van Schalkwyk, John M. Kelly, Martin C. Taylor, Janette Reader, Lyn-Marie Birkholtz, David R. Lisgarten, Jeremy K. Cockcroft, John N. Lisgarten, Rex A. Palmer, Rosemary C. Talbert, Steven D. Shnyder, Colin W. Wright
Publicado em 2022-04-01

MARKETING STUDIES OF LOCAL MARKET OF DRUGS WHICH ARE APPLIED FOR PREVENTION AND TREATMENT OF ORAL CAVITY DISEASES

Por O. A. Tsarakhov, L. N. Tsarakhova
Publicado em 2015-11-01